Biotech

All Articles

F 2G increases $100M for second try to get new antifungal to market

.After F2G's 1st effort to get a brand-new course of antifungal to market was derailed due to the FD...

Moderna targets $1.1 B in R&ampD spending slices, drops 5 programs among success tensions

.Moderna has pledged to cut R&ampD spending by $1.1 billion through 2027. The decision to retract th...

Sanofi's $80M bank on Fulcrum dystrophy medication finishes in period 3 lose big

.Only 4 months after Sanofi wager $80 thousand in upfront cash money on Pivot Therapies' losmapimod,...

Oncternal equity sinks 60% amidst layoffs, trial discontinuations

.Cancer provider Oncternal Therapeutics is actually folding all its own medical tests as well as lay...

Roche is carrying out hopes that its injectable weight problems possibility can at some point display 25% weight management in late-stage test

.Roche is actually holding out hopes that its injectable weight problems possibility could eventuall...

Novo Nordisk hails 'remarkable' weight loss lead for dual-acting oral medication in very early test

.Novo Nordisk has actually lifted the cover on a stage 1 test of its own dental amylin and also GLP-...

AbbVie sues BeiGene over blood stream cancer cells medication secret method

.Just a few brief full weeks after winning an FDA Fast Track tag for its investigational BTK degrade...

Lilly delivers one-two blow along with second tranche of beneficial records on regular insulin candidate

.Shortly after a good information decline for Eli Lilly's efsitora alfa, the Indianapolis-based firm...

BridgeBio cuts genetics therapy budget as medical data let down

.BridgeBio Pharma is slashing its own genetics therapy spending plan as well as pulling back from th...

GSK gives up HSV injection hopes after period 2 fall short, resigning ethnicity to Moderna, BioNTech

.GSK's try to develop the very first vaccination for genital herpes simplex infection (HSV) has actu...